Oleg Zernovak, M.D.
About Oleg Zernovak, M.D.
Oleg Zernovak, M.D., is the Executive Director of Hematology at BeiGene in the United States. He has extensive experience in hematological and solid tumors oncology, having held various senior roles in clinical development and medical affairs across multiple pharmaceutical companies.
Company
Oleg Zernovak, M.D., currently holds the position of Executive Director, Hematology at BeiGene in the United States. BeiGene is a global biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide.
Professional Title and Experience
As the Executive Director of Hematology at BeiGene, Oleg Zernovak, M.D., leverages extensive experience in both hematological and solid tumors oncology. He is skilled in conducting phase I, II, and III clinical trials, along with expertise in observational studies and regulatory interactions. His professional background includes senior leadership roles and clinical development positions across various renowned pharmaceutical and biotechnology companies.
Previous Roles and Responsibilities
Before his current role at BeiGene, Oleg Zernovak served as a Consultant in 2023, after his tenure as VP Clinical Development at Curis in 2022. He was a Senior Medical Director at Cellectis from 2020 to 2022 in the New York City Metropolitan Area. From 2018 to 2020, he worked at Janssen Inc. as Senior Director Clinical Development in Raritan, New Jersey. Prior to that, he held the position of Medical Director/Global Clinical Lead at Daiichi Sankyo, Inc. in Basking Ridge, New Jersey from 2014 to 2018.
Educational Background and Medical Expertise
Oleg Zernovak earned his Doctor of Medicine (M.D.) degree in Pediatrics from Azerbaijan Medical University. His medical expertise spans across both hematology and oncology, with significant proficiency in medical affairs and clinical trial management. Dr. Zernovak’s comprehensive medical education and subsequent professional journey have equipped him with a robust understanding of disease management and innovative treatment approaches.
Career Development and Key Positions
Throughout his career, Oleg Zernovak has held numerous prominent roles within the pharmaceutical industry. He was Senior Medical Director, US Disease Lead for MDS and AML at Celgene from 2012 to 2014 and Global Medical Director, CML Franchise at Novartis from 2009 to 2012. Earlier in his career, he served as Medical Liaison for Melanoma and Neurooncology at Schering-Plough in California from 2004 to 2009, and as Scientific Affairs Manager for CLL, NHL, and supportive care at Berlex in the Greater Los Angeles Area from 2002 to 2004.